Dynavax Technologies Corporation Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 63.83. In total, the insiders bought 1 881 568 and sold 442 563 DVAX shares in the last 100 trades.

Insider Power

(Last 100 transactions)
63.83
Buy 1 881 568 Shares
Sell 442 563 Shares

Historical Insider Trades

Date Type Action Person Amount
May 31, 2024 Common Stock Sell Cano Francis 3 615
May 24, 2024 Common Stock Buy Cano Francis 7 500
May 24, 2024 Common Stock Sell Cano Francis 3 885
May 24, 2024 Stock Option (Right to Buy) Buy Cano Francis 7 500
May 23, 2024 Common Stock Buy Myers Scott Dunseth 5 357
May 23, 2024 Stock Option (Right to Buy) Buy Myers Scott Dunseth 22 500
May 23, 2024 Stock Option (Right to Buy) Buy Eastland Julia Marie 22 500
May 23, 2024 Common Stock Buy Eastland Julia Marie 5 357
May 23, 2024 Stock Option (Right to Buy) Buy Kisner Daniel L 22 500
May 23, 2024 Common Stock Buy Kisner Daniel L 5 357
May 23, 2024 Stock Option (Right to Buy) Buy Macgregor Brent 22 500
May 23, 2024 Common Stock Buy Macgregor Brent 5 357
May 23, 2024 Stock Option (Right to Buy) Buy Paradiso Peter R. 22 500
May 23, 2024 Common Stock Buy Paradiso Peter R. 5 357
May 23, 2024 Common Stock Buy Phillips Peggy V 5 357
May 23, 2024 Stock Option (Right to Buy) Buy Phillips Peggy V 22 500
May 23, 2024 Common Stock Buy Sun Elaine D 5 357
May 23, 2024 Stock Option (Right to Buy) Buy Sun Elaine D 22 500
May 23, 2024 Common Stock Buy Cano Francis 5 357
May 23, 2024 Stock Option (Right to Buy) Buy Cano Francis 22 500
Mar 29, 2024 Common Stock Buy Slebir John L 0
Mar 29, 2024 Stock Options (Right to Buy) Buy Slebir John L 88 000
Mar 29, 2024 Stock Option (Right to Buy) Buy Slebir John L 300 000
Mar 29, 2024 Stock Options (Right to Buy) Buy Slebir John L 80 000
Mar 29, 2024 Restricted Stock Unit Buy Slebir John L 50 000
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT